The spectrum of WRN mutations in Werner syndrome patients.
The International Registry of Werner syndrome (www.wernersyndrome.org) has been providing molecular diagnosis of the Werner syndrome (WS) for the past decade. The present communication summarizes, from among 99 WS subjects, the spectrum of 50 distinct mutations discovered by our group and by others since the WRN gene (also called RECQL2 or REQ3) was first cloned in 1996; 25 of these have not previously been published. All WRN mutations reported thus far have resulted in the elimination of the nuclear localization signal at the C-terminus of the protein, precluding functional interactions in the nucleus; thus, all could be classified as null mutations. We now report two new mutations in the N-terminus that result in instability of the WRN protein. Clinical data confirm that the most penetrant phenotype is bilateral ocular cataracts. Other cardinal signs were seen in more than 95% of the cases. The median age of death, previously reported to be in the range of 46-48 years, is 54 years. Lymphoblastoid cell lines (LCLs) have been cryopreserved from the majority of our index cases, including material from nuclear pedigrees. These, as well as inducible and complemented hTERT (catalytic subunit of human telomerase) immortalized skin fibroblast cell lines are available to qualified investigators.
Huang
Shurong
S
Department of Pathology, University of Washington, Seattle, Washington 98195-7470, USA.
Lee
Lin
L
Hanson
Nancy B
NB
Lenaerts
Catherine
C
Hoehn
Holger
H
Poot
Martin
M
Rubin
Craig D
CD
Chen
Da-Fu
DF
Yang
Chih-Chao
CC
Juch
Heike
H
Dorn
Thomas
T
Spiegel
Roland
R
Oral
Elif Arioglu
EA
Abid
Mohammed
M
Battisti
Carla
C
Lucci-Cordisco
Emanuela
E
Neri
Giovanni
G
Steed
Erin H
EH
Kidd
Alexa
A
Isley
William
W
Showalter
David
D
Vittone
Janet L
JL
Konstantinow
Alexander
A
Ring
Johannes
J
Meyer
Peter
P
Wenger
Sharon L
SL
von Herbay
Axel
A
Wollina
Uwe
U
Schuelke
Markus
M
Huizenga
Carin R
CR
Leistritz
Dru F
DF
Martin
George M
GM
Mian
I Saira
IS
Oshima
Junko
J